Principal Investigator
Gilberto Lopes
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20210977
Clinical Trial Summary
A Phase 1/2 Study of the Highly Selective ROS1 Inhibitor NVL-520 in
Patients with Advanced NSCLC and Other Solid Tumors (ARROS-1)
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647